With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
F.D.A. Looks to A.I. to Enhance Efficiency
Written by
in
Artificial Intelligence, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Federal Budget (US), Food, Food and Drug Administration, Health and Human Services Department, Kennedy, Robert F Jr, Makary, Marty, Medical Devices, Prasad, Vinayak K, Regulation and Deregulation of Industry, Trump, Donald J, United States Politics and Government